Cancer patients hoping to be part of a clinical trial for a new therapy often have difficulty locating and applying for such trials, while the contract research organizations (CROs) managing the trials often have difficulty recruiting patients.
Belong.Life, an Israeli-founded group of patient communities and care platforms, is making clinical trial matching and recruitment easier with the launch of Tara, a conversational AI cancer clinical trial matching platform.
